Cargando…
Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases
Neurotransmitter depletion and mitochondrial dysfunction are among the multiple pathological events that lead to neurodegeneration. Following our previous studies related with the development of multitarget mitochondriotropic antioxidants, this study aims to evaluate whether the π-system extension o...
Autores principales: | Chavarria, Daniel, Da Silva, Ophelie, Benfeito, Sofia, Barreiro, Sandra, Garrido, Jorge, Cagide, Fernando, Soares, Pedro, Remião, Fernando, Brazzolotto, Xavier, Nachon, Florian, Oliveira, Paulo J., Dias, José, Borges, Fernanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926627/ https://www.ncbi.nlm.nih.gov/pubmed/33672269 http://dx.doi.org/10.3390/antiox10020329 |
Ejemplares similares
-
Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer’s Disease Pathophysiological Hallmarks
por: Benfeito, Sofia, et al.
Publicado: (2020) -
Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors
por: Oliveira, Catarina, et al.
Publicado: (2018) -
Unraveling the In Vitro Toxicity Profile of Psychedelic 2C Phenethylamines and Their N-Benzylphenethylamine (NBOMe) Analogues
por: Martins, Daniel, et al.
Publicado: (2023) -
Research Models to Study Ferroptosis’s Impact in Neurodegenerative Diseases
por: Costa, Inês, et al.
Publicado: (2023) -
Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles
por: Pinto, Miguel, et al.
Publicado: (2019)